Zentalis Pharmaceuticals, Inc. Common Stock ZNTL
$2.60
-3.70%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-139,545,000
- Net Margin
- —
- Return on Equity
- -97.15%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.78
- Price / Sales
- —
Over the trailing twelve months, Zentalis Pharmaceuticals, Inc. Common Stock generated revenue of — and net income of $-139,545,000.
Key Stats
- Last Close
- $2.60
- Market Cap
- $255.61 million
- 52-Week Range
- $1.21 – $6.95
- Average Volume
- 1.01 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.